In the following work, a systematic review and quantitative meta-analyses were performed to test relationships between these three potential biomarkers in CSF (Aβ(1-42), T-tau, and P-tau) and the evolution of AD in longitudinal evaluations of levels relative to baseline, using prior-published experimental data. Here, MAPT is linked to Alzheimer disease.